Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Securities Code: 4205 June 5, 2024
To our shareholders,
Kimiaki Tanaka Chairman
Zeon Corporation
1-6-2 Marunouchi, Chiyoda-ku, Tokyo, Japan
NOTICE OF THE 99th ANNUAL GENERAL MEETING OF SHAREHOLDERS
We hereby notify that the 99th Annual General Meeting of Shareholders of Zeon Corporation ("the Company") will be held as described hereunder.
The Company has taken measures for electronic provision when convening this General Meeting of Shareholders, so please access the URL of the Company's website below which contains information on the items subject to the electronic provision measures.
The Company's website: https://www.zeon.co.jp/ir/stock/meeting/ (in Japanese)
Items subject to measures for electronic provision are also available on the following websites. For the Tokyo Stock Exchange (TSE) website, input "Zeon Corporation" into "issue name" (company name) or input "4205" into "securities code," and click "Search," and then click "Basic information" and select "Documents for public inspection/PR information."
PRONEXUS INC. Website: https://d.sokai.jp/4205/teiji/ (in Japanese)
TSE Website: https://www2.jpx.co.jp/tseHpFront/JJK010010Action.do?Show=Show (in Japanese)
Instead of attending the meeting on the day, you can also exercise your voting rights in writing or over the Internet. Please review the Reference Materials for General Meeting of Shareholders and exercise your voting rights in either of the following methods:
[Voting via mail]
Please indicate your approval or disapproval of each of the items to be resolved on the Voting Rights Exercise Form and return it to the Company by mail.
[Voting via the Internet, etc.]
Please access the website designated by the Company for the exercise of voting rights and follow on-screen instructions to enter your approval or disapproval of each of the items to be resolved.
1. Date and Time Thursday, June 27, 2024, at 10:00 a.m. (JST)
(Reception will open at 9:30 a.m.)
2. Venue Station Conference Tokyo (Sapia Tower, 6F) 1-7-12 Marunouchi, Chiyoda-ku, Tokyo, Japan
3. Purpose of the Meeting Items to be reported:
- The business report, the consolidated financial statements for the 99th fiscal year (from April 1, 2023 to March 31, 2024) and the audit reports of the Accounting Auditor and the Audit & Supervisory Board regarding the consolidated financial statements for the 99th fiscal year
- The non-consolidated financial statements for the 99th fiscal year (from April 1, 2023 to March 31, 2024)
- 1 -
Items to be resolved:
Proposal No. 1: Appropriation of Surplus
Proposal No. 2: Election of Eleven (11) Directors
Proposal No. 3: Election of Three (3) Audit & Supervisory Board Members
4. Information on Exercise of Voting Rights
- Please exercise your voting rights by completing the Voting Rights Exercise Form and returning it to us by mail to arrive, or by registering your votes via the Internet, no later than 5:10 p.m. on Wednesday, June 26, 2024 (JST).
- In the event that you exercise your voting rights via mail, the Company will deem that you indicated your approval of a proposal if neither approval nor disapproval of a proposal is indicated.
- In the event that you exercise your voting rights both via mail and via the Internet, etc., the vote via the Internet, etc. shall be upheld as the valid exercise of your voting rights. Moreover, if you exercise your voting rights multiple times via the Internet, etc. and your multiple votes for the same proposal are inconsistent, your last vote shall be upheld as the valid exercise of your voting rights.
- If attending the meeting in person, please present the enclosed Voting Rights Exercise Form at the reception desk.
- If revisions to the items subject to measures for electronic provision arise, a notice of the revisions and the details of the items before and after the revisions will be posted on the Company's website, PRONEXUS INC. website and the TSE website.
- In accordance with the provisions of laws and regulations and Article 15 of the Articles of Incorporation of the Company, the Notes to Consolidated Financial Statements and Notes to Non-consolidated Financial Statements are not presented in the paper-based documents to be delivered to shareholders who requested the delivery of paper-based documents. Accordingly, the said documents are part of the documents that were audited by the Audit & Supervisory Board Members and the Accounting Auditor in preparing the respective Audit Reports.
- 2 -
Reference Materials for General Meeting of Shareholders
Proposals and references
Proposal No. 1: Appropriation of Surplus
The Company has adopted the basic policy of paying stable and continuous dividends of surplus to shareholders. Additionally, we aim to maintain a dividend payout ratio of 30% or more, striving to enhance shareholder returns. Under this policy, the year-end dividend for the fiscal year ended March 31, 2024 is proposed to be ¥25 per share as described below. As a result, including the interim dividend, the annual dividend would be ¥45 per share (a dividend payout ratio of 30.6%), an increase of ¥9 per share from the previous fiscal year.
Matters concerning the year-end dividend
-
Items concerning allocation of dividend assets and the total amount for shareholders thereof ¥25.00 per share of common stock of the Company
The total amount of dividends: ¥5,318,772,775 - Effective date of dividends of surplus June 28, 2024
- 3 -
Proposal No. 2: Election of Eleven (11) Directors
The terms of office of all eleven (11) incumbent Directors will expire at the conclusion of this Annual General Meeting of Shareholders. Therefore, we would like you to approve the election of eleven (11) Directors (eight (8) males and three (3) females) including five (5) Outside Directors.
The candidates for Directors are as follows:
No. | Name | Current position and responsibility | Attribute | |
1 | Kimiaki Tanaka | Chairman | Reelection | |
Male | ||||
2 | Tetsuya Toyoshima | President and CEO | Reelection | |
Male | ||||
Director and Senior Corporate Officer | Reelection | |||
3 | Kazuyoshi Matsuura | Head of Elastomers and Chemicals Business Headquarters | ||
Male | ||||
Director of Tohpe Corporation | ||||
4 | Yoshiyuki Sone | Director and Senior Corporate Officer | Reelection | |
Head of Administrative Headquarters | Male | |||
Director and Senior Corporate Officer | Reelection | |||
5 | Yuichiro Konishi | Head of Specialty Business Headquarters and Division Manager | ||
Male | ||||
of Specialty Plastics Division | ||||
Director and Corporate Officer | Reelection | |||
6 | Erisa Watanabe | Head of Corporate Sustainability Headquarters and Division | ||
Female | ||||
Manager of Corporate Sustainability Division | ||||
Outside Director | Reelection | |||
Male | ||||
7 | Takao Kitabata | President of KAISHI PROFESSIONAL UNIVERSITY, Niigata | ||
Outside | ||||
Sogo Gakuin Academic Corporation | ||||
Independent | ||||
Outside Director | Reelection | |||
Male | ||||
8 | Tadanobu Nagumo | Member of the Board (Outside) and Chairperson of the Board of | ||
Outside | ||||
ROHM Co., Ltd. | ||||
Independent | ||||
Outside Director | Reelection | |||
9 | Fumiaki Ikeno | Program Director (U.S.) of Japan Biodesign, Stanford Biodesign | Male | |
Board Member and Chief Medical Officer of MedVenture | Outside | |||
Partners, Inc. | Independent | |||
Outside Director | Reelection | |||
Female | ||||
10 | Miki Akiyama | Professor, Faculty of Environment and Information Studies of | ||
Outside | ||||
Keio University | ||||
Independent | ||||
Reelection | ||||
11 | Saeko Masumi | Outside Director | Female | |
Attorney, Sengokuyama Law Office | Outside | |||
Independent | ||||
Reelection: Candidate for reelection as Director | ||||
Outside: Candidate for Outside Director | ||||
Independent: Independent officer as provided by securities exchanges, etc. |
- 4 -
Name | Number of the | |||
No. | Career summary, position and responsibility at the Company | Company's shares | ||
(Date of birth) | ||||
held | ||||
Apr. 1979 | Joined the Company | |||
Kimiaki Tanaka | June 2005 | Director of the Company | ||
June 2007 | Director & Corporate Officer of the Company | |||
(February 19, 1953) | ||||
June 2011 | Director & Senior Corporate Officer of the | |||
Reelection | Company | |||
June 2012 | Director & Executive Corporate Officer of the | 142,630 | ||
Male | ||||
Company | ||||
Attendance at Board of | ||||
June 2013 | President and CEO of the Company | |||
1 | Directors meetings | |||
June 2023 | Chairman of the Company (incumbent) | |||
18/18 | ||||
(Status of important concurrent occupations) | ||||
- | ||||
[Reasons for nomination as candidate for Director] | ||||
Mr. Kimiaki Tanaka became President and CEO of the Company in 2013, and since 2023, he has served as Chairman. | ||||
Throughout his tenure as president, Mr. Tanaka has long served as a driving force for the Group, leading management | ||||
and contributing to the enhancement of corporate value and development of the Company's business. The Company has | ||||
nominated him as candidate for Director again as it expects him to offer leadership based on his extensive knowledge | ||||
and experience concerning management in general. | ||||
Tetsuya Toyoshima | Apr. 1989 | Joined the Company | ||
June 2015 | Corporate Officer of the Company | |||
(March 13, 1963) | ||||
June 2020 | Senior Corporate Officer of the Company | |||
Reelection | June 2022 | Director & Senior Corporate Officer of the | 10,430 | |
Company | ||||
Male | ||||
June 2023 | President and CEO of the Company | |||
Attendance at Board of | ||||
(incumbent) | ||||
2 | Directors meetings | |||
(Status of important concurrent occupations) | ||||
18/18 | ||||
- | ||||
[Reasons for nomination as candidate for Director] | ||||
Mr. Tetsuya Toyoshima became President and CEO of the Company in 2023, and he has contributed to improvement of | ||||
the corporate value of the Group, including directing management by leading promotion of the "STAGE30 Phase 2" | ||||
Mid-Term Management Plan. The Company has nominated him as candidate for Director again as it expects him to | ||||
offer leadership based on his extensive knowledge and experience concerning management in general. | ||||
Kazuyoshi Matsuura | Apr. 1993 | Joined the Company | ||
(February 21, 1967) | June 2017 | Corporate Officer of the Company | ||
Reelection | June 2019 | Director & Corporate Officer of the Company | ||
June 2022 | Director & Senior Corporate Officer of the | 24,230 | ||
Male | Company (incumbent) | |||
3 | Attendance at Board of | (Status of important concurrent occupations) | ||
Directors meetings | Director of Tohpe Corporation | |||
18/18 | ||||
[Reasons for nomination as candidate for Director] | ||||
Mr. Kazuyoshi Matsuura became Director in 2019 and currently serves as Head of Elastomers and Chemicals Business | ||||
Headquarters and Director of Tohpe Corporation. The Company has nominated him as candidate for Director again as it | ||||
judges that his extensive operational knowledge and experience make him suited to playing a role in the Company's | ||||
management. | ||||
Yoshiyuki Sone | Apr. 1988 | Joined the Company | ||
(June 6, 1965) | June 2018 | Corporate Officer of the Company | ||
Reelection | June 2020 | Senior Corporate Officer of the Company | ||
June 2022 | Director & Senior Corporate Officer of the | 13,330 | ||
Male | Company (incumbent) | |||
4 | Attendance at Board of | (Status of important concurrent occupations) | ||
Directors meetings | - | |||
18/18 | ||||
[Reasons for nomination as candidate for Director] | ||||
Mr. Yoshiyuki Sone became Director of the Company in 2022 and currently serves as Head of Administrative | ||||
Headquarters. The Company has nominated him as candidate for Director again as it judges that his extensive | ||||
operational knowledge and experience make him suited to playing a role in the Company's management. |
- 5 -
Name | Number of the | |||
No. | Career summary, position and responsibility at the Company | Company's shares | ||
(Date of birth) | ||||
held | ||||
Apr. 1991 | Joined the Company | |||
July 2011 | Joined Solvay Advanced Polymers K.K. | |||
July 2012 | Joined the Company | |||
Yuichiro Konishi | July 2013 | Division Manager of Electronic Materials | ||
Division 1 of the Company | ||||
(August 30, 1965) | ||||
July 2015 | Division Manager of Electronic Materials | |||
Reelection | Division and Resident Director of the Taiwan | |||
Office of Electronic Materials Division of the | 10,630 | |||
Male | ||||
Company | ||||
Attendance at Board of | ||||
June 2020 | Corporate Officer of the Company | |||
5 | Directors meetings | |||
June 2022 | Director & Corporate Officer of the Company | |||
18/18 | ||||
June 2023 | Director & Senior Corporate Officer of the | |||
Company (incumbent) | ||||
(Status of important concurrent occupations) | ||||
- | ||||
[Reasons for nomination as candidate for Director] | ||||
Mr. Yuichiro Konishi became Director in 2022 and currently serves as Head of Specialty Business Headquarters and | ||||
Division Manager of Specialty Plastics Division. The Company has nominated him as candidate for Director again as it | ||||
judges that his extensive operational knowledge and experience make him suited to playing a role in the Company's | ||||
management. | ||||
Erisa Watanabe | Apr. 1987 | Joined the Company | ||
(February 25, 1965) | Apr. 2013 | General Manager of Materials Procurement | ||
Department, Production Center of the Company | ||||
Reelection | June 2018 | Corporate Officer of the Company | 14,930 | |
Female | June 2022 | Director & Corporate Officer of the Company | ||
Attendance at Board of | (incumbent) | |||
6 | Directors meetings | (Status of important concurrent occupations) | ||
18/18 | - | |||
[Reasons for nomination as candidate for Director] | ||||
Ms. Erisa Watanabe became Director of the Company in 2022 and currently serves as Head of Corporate Sustainability | ||||
Headquarters and Division Manager of Corporate Sustainability Division. The Company has nominated her as | ||||
candidate for Director again as it judges that her extensive operational knowledge and experience make her suited to | ||||
playing a role in the Company's management. |
- 6 -
Name | Number of the | |||
No. | Career summary, position and responsibility at the Company | Company's shares | ||
(Date of birth) | ||||
held | ||||
Apr. 1972 | Joined Ministry of International Trade and | |||
Industry | ||||
June 2004 | Director-General, Economic and Industrial | |||
Policy Bureau of Ministry of Economy, Trade | ||||
and Industry | ||||
July 2006 | Vice-Minister of Economy, Trade and Industry | |||
July 2008 | Retired from Ministry of Economy, Trade and | |||
Takao Kitabata | Industry | |||
June 2010 | Outside Director of Kobe Steel, Ltd. | |||
(January 10, 1950) | ||||
Outside Audit & Supervisory Board Member of | ||||
Reelection | Marubeni Corporation | |||
June 2013 | Chairman of Board of Sanda Gakuen Junior | |||
Male | ||||
High School & Senior High School | 0 | |||
Outside | ||||
Outside Director of Marubeni Corporation | ||||
Independent | ||||
Apr. 2014 | Principal of Sanda Gakuen Junior High School | |||
Attendance at Board of | ||||
& Senior High School | ||||
Directors meetings | ||||
June 2014 | Outside Director of the Company (incumbent) | |||
7 | 17/18 | |||
Apr. 2020 | President of KAISHI PROFESSIONAL | |||
UNIVERSITY, Niigata Sogo Gakuin Academic | ||||
Corporation (incumbent) | ||||
(Status of important concurrent occupations) | ||||
President of KAISHI PROFESSIONAL UNIVERSITY, Niigata | ||||
Sogo Gakuin Academic Corporation | ||||
Outside Director of SEIREN CO., LTD. | ||||
Outside Director of Miroku Corporation | ||||
[Reasons for nomination as candidate for Outside Director and outline of expected role] | ||||
Mr. Takao Kitabata was involved in the planning of economic and industrial policy for many years, and he possesses | ||||
experience and knowledge of industry overall, which he has accumulated through his career. The Company has | ||||
nominated him as candidate for Outside Director again, as it expects that, regardless of whether he has had direct | ||||
involvement in the corporate management of a company, he can contribute to the corporate management of the | ||||
Company with his guidance and advice based on his knowledge, etc. In addition, if he is elected, he will provide advice | ||||
mainly on the Company's policy related to the nomination of executive candidates and policies related to decisions of | ||||
the remuneration as a member of the Director and Officer Nomination and Remuneration Committee from an | ||||
independent standpoint. At the conclusion of this Annual General Meeting of Shareholders, he will have served ten (10) | ||||
years as Outside Director of the Company. |
- 7 -
Name | Number of the | |||
No. | Career summary, position and responsibility at the Company | Company's shares | ||
(Date of birth) | ||||
held | ||||
Apr. 1969 | Joined The Yokohama Rubber Co., Ltd. | |||
June 1999 | Director of The Yokohama Rubber Co., Ltd. | |||
June 2002 | Managing Director of The Yokohama Rubber | |||
Co., Ltd. | ||||
June 2003 | Senior Managing Director of The Yokohama | |||
Tadanobu Nagumo | Rubber Co., Ltd. | |||
June 2004 | President and Representative Director of The | |||
(February 12, 1947) | ||||
Yokohama Rubber Co., Ltd. | ||||
Reelection | June 2011 | Chairman and CEO and Representative | ||
Director of The Yokohama Rubber Co., Ltd. | ||||
Male | ||||
Outside Audit & Supervisory Board Member of | 13,700 | |||
Outside | ||||
the Company | ||||
Independent | ||||
June 2015 | Outside Director of the Company (incumbent) | |||
Attendance at Board of | ||||
Mar. 2016 | Chairman and Representative Director of The | |||
Directors meetings | ||||
Yokohama Rubber Co., Ltd. | ||||
8 | 18/18 | |||
Mar. 2019 | Senior Advisor of The Yokohama Rubber Co., | |||
Ltd. (retired in March 2024) | ||||
(Status of important concurrent occupations) | ||||
Member of the Board (Outside) and Chairperson of the Board of | ||||
ROHM Co., Ltd. | ||||
[Reasons for nomination as candidate for Outside Director and outline of expected role]
Mr. Tadanobu Nagumo was involved in the management of The Yokohama Rubber Co., Ltd. for many years, and he possesses experience and knowledge as a person with expertise in corporate management, which he has accumulated through his career. The Company has nominated him as candidate for Outside Director again, as it expects him to provide practical guidance and advice related to corporate management of the Company founded on his experience, etc. In addition, if he is elected, he will provide advice mainly on the Company's policy related to the nomination of executive candidates and policies related to decisions of the remuneration as a member of the Director and Officer Nomination and Remuneration Committee from an independent standpoint. At the conclusion of this Annual General Meeting of Shareholders, he will have served nine (9) years as Outside Director of the Company, but he served four (4) years as Outside Audit & Supervisory Board Member from June 2011.
- 8 -
Name | Number of the | |||
No. | Career summary, position and responsibility at the Company | Company's shares | ||
(Date of birth) | ||||
held | ||||
Mar. 1992 | Graduated from Division of Medicine, School | |||
of Medicine of Jichi Medical University | ||||
Apr. 1992 | Joined Shizuoka Prefectural Government | |||
Technical Officer of Health and Welfare | ||||
Division, Health and Welfare Department of | ||||
Shizuoka Prefectural Government | ||||
Apr. 2001 | Post-Doctoral Fellow of Division of | |||
Cardiovascular Medicine, Department of | ||||
Medicine, School of Medicine of Stanford | ||||
University | ||||
Apr. 2004 | Research Associate and Medical Director of | |||
Experimental Interventional Laboratory, | ||||
Division of Cardiovascular Medicine, | ||||
Department of Medicine, School of Medicine | ||||
of Stanford University | ||||
June 2007 | Completed Biodesign Program of Stanford | |||
University | ||||
Fumiaki Ikeno | Oct. 2013 | Co-founder of MedVenture Partners, Inc. | ||
Board Member and Chief Medical Officer of | ||||
(May 4, 1967) | ||||
MedVenture Partners, Inc. (incumbent) | ||||
Reelection | Co-founder of (NPO) US-Japan MedTech | |||
Frontiers (USJMF), Board Member of (NPO) | ||||
Male | ||||
US-Japan MedTech Frontiers (USJMF) | 0 | |||
Outside | ||||
Apr. 2015 | Program Director (U.S.) of Japan Biodesign, | |||
Independent | ||||
Stanford Biodesign (incumbent) | ||||
Attendance at Board of | ||||
Researcher of Division of Cardiovascular | ||||
Directors meetings | ||||
Medicine, Department of Medicine, School of | ||||
18/18 | ||||
9 | Medicine of Stanford University (incumbent) | |||
Apr. 2018 | Director of Japan Outreach of Stanford Center | |||
for Asian Health Research and Education | ||||
(CARE) (incumbent) | ||||
Sept. 2019 | Co-Director of SPARK Asian Pacific of | |||
Stanford SPARK Program (SPARK Global) | ||||
(incumbent) | ||||
June 2021 | Outside Director of the Company (incumbent) | |||
(Status of important concurrent occupations) | ||||
Program Director (U.S.) of Japan Biodesign, Stanford Biodesign | ||||
Director of Japan Outreach of Stanford Center for Asian Health | ||||
Research and Education (CARE) | ||||
Co-Director of SPARK Asian Pacific of Stanford SPARK | ||||
Program (SPARK Global) | ||||
Researcher of Division of Cardiovascular Medicine, Department | ||||
of Medicine, School of Medicine of Stanford University | ||||
Board Member and Chief Medical Officer of MedVenture | ||||
Partners, Inc. | ||||
[Reasons for nomination as candidate for Outside Director and outline of expected role] | ||||
Mr. Fumiaki Ikeno possesses experience and insight acquired through the involvement in the development of medical | ||||
device products for many years as a physician and medical researcher, and knowledge on the medial industry overall, | ||||
which he has accumulated through his career as a venture capitalist specializing in medical devices. Based on such | ||||
experience, etc., the Company has nominated him as candidate for Outside Director again, as it expects him to provide | ||||
useful guidance and advice related to the Company's research and development, innovation, and business development. | ||||
In addition, if he is elected, he will provide advice mainly on the Company's policy related to the nomination of | ||||
executive candidates and policies related to decisions of the remuneration as a member of the Director and Officer | ||||
Nomination and Remuneration Committee from an independent standpoint. At the conclusion of this Annual General | ||||
Meeting of Shareholders, he will have served three (3) years as Outside Director of the Company. |
- 9 -
Name | Number of the | |||
No. | Career summary, position and responsibility at the Company | Company's shares | ||
(Date of birth) | ||||
held | ||||
Mar. 1991 | Graduated from Department of Political | |||
Science, Faculty of Law of Keio University | ||||
Apr. 1991 | Joined Sendai Television Incorporated | |||
Nov. 2001 | MSc, London School of Economics and | |||
Political Science | ||||
Apr. 2005 | Assistant Professor (Non-Tenured), Graduate | |||
School of Media and Governance, Keio | ||||
University | ||||
Sept. 2005 | Withdrawal after completion of doctoral course | |||
requirements, Graduate School of Media and | ||||
Governance, Keio University | ||||
Dec. 2006 | Obtained Ph.D. in Media and Governance | |||
Apr. 2007 | Assistant Professor, Faculty of Policy | |||
Management of Keio University | ||||
Apr. 2010 | Associate Professor, Faculty of Policy | |||
Management of Keio University | ||||
Apr. 2011 | Associate Professor, School of Medicine of | |||
Keio University | ||||
Apr. 2012 | Associate Professor, Faculty of Environment | |||
and Information Studies of Keio University | ||||
Graduate School Committee Member, Graduate | ||||
Miki Akiyama | School of Media and Governance, Keio | |||
(February 13, 1968) | University (incumbent) | |||
Apr. 2015 | Graduate School Committee Member, Graduate | |||
Reelection | School of Health Management, Keio University | |||
10 | Female | (incumbent) | 0 | |
Outside | Dec. 2015 | Obtained Ph.D. in Medicine | ||
Independent | Mar. 2016 | Visiting Scholar, University of California, | ||
Attendance at Board of | Berkeley | |||
Directors meetings | Apr. 2017 | Professor, Faculty of Environment and | ||
13/13 | Information Studies of Keio University | |||
(incumbent) | ||||
Professor, School of Medicine of Keio | ||||
University (incumbent) | ||||
Professor, K-FRECS at Tsuruoka, Institute for | ||||
Advanced Biosciences, Keio University | ||||
(incumbent) | ||||
June 2019 | Public Interest Committee Member, Central | |||
Social Insurance Medical Council | ||||
June 2023 | Outside Director of the Company (incumbent) | |||
(Status of important concurrent occupations) | ||||
Professor, Faculty of Environment and Information Studies of | ||||
Keio University | ||||
Professor, School of Medicine of Keio University | ||||
Professor, K-FRECS at Tsuruoka, Institute for Advanced | ||||
Biosciences, Keio University | ||||
Graduate School Committee Member, Graduate School of | ||||
Media and Governance, Keio University | ||||
Graduate School Committee Member, Graduate School of | ||||
Health Management, Keio University | ||||
Trustee, Public Interest Incorporated Foundation Health Care | ||||
Science Institute |
- 10 -
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Zeon Corporation published this content on 29 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 May 2024 15:15:17 UTC.